Mitochondrial DNA sequence data reveals association of haplogroup U with psychosis in bipolar disorder

Journal of Psychiatric Research

Volumn 84, Issue , 2017, Pages 221-226

  Frye, Mark A ^a   Ryu, Euijung ^a   Nassan, Malik ^a   Jenkins, Gregory D ^a   Andreazza, Ana C ^b   Evans, Jared M ^a   McElroy, Susan L ^c   Oglesbee, Devin ^a   Highsmith, W Edward ^a   Biernacka, Joanna M ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c LINDNER CENTER OF HOPE   (United States)

Author keywords

Bipolar disorder; Haplogroup; Mitochondrial DNA; Psychosis; Single nucleotide variants

Indexed keywords

MITOCHONDRIAL DNA; ND4 PROTEIN; ND5 PROTEIN; PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; TRANSFER RNA; UNCLASSIFIED DRUG; MITOCHONDRIAL PROTEIN; NADH DEHYDROGENASE SUBUNIT 4; ND5 PROTEIN, HUMAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ADOLESCENT DISEASE; ADULT; AGED; ALLELE; ARTICLE; BIPOLAR I DISORDER; CLINICAL EVALUATION; CONTROLLED STUDY; DNA SEQUENCE; EUROPEAN; FEMALE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIATION; HAPLOGROUP U; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL HAPLOGROUP; ND4 GENE; ND5 GENE; ONSET AGE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PSYCHOSIS; RAPID CYCLING BIPOLAR DISORDER; RESPIRATORY CHAIN; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE NUCLEOTIDE VARIANT; ADOLESCENT; BIPOLAR DISORDER; CAUCASIAN; COMPLICATION; CROSS-SECTIONAL STUDY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; MIDDLE AGED; PHENOTYPE; PSYCHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIPOLAR DISORDER; CROSS-SECTIONAL STUDIES; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT COMPLEX I; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; NADH DEHYDROGENASE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOTIC DISORDERS; YOUNG ADULT;

EID: 84992220353     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2016.09.027     Document Type: Article

References (65)

1. Andreazza, A.C., Frey, B.N., Erdtmann, B., Salvador, M., Rombaldi, F., Santin, A., Goncalves, C.A., Kapczinski, F., DNA damage in bipolar disorder. Psychiatry Res. 153:1 (2007), 27–32.
2. Andreazza, A.C., Young, L.T., The neurobiology of bipolar disorder: identifying targets for specific agents and synergies for combination treatment. Int. J. Neuropsychopharmacol. 17:7 (2014), 1039–1052.
3. Andreazza, A.C., Young, L.T., The neurobiology of bipolar disorder: identifying targets for specific agents and synergies for combination treatment. Int. J. Neuropsychopharmacol. offic. Sci. J. Coll. Int. Neuropsychopharmacol. 17:7 (2014), 1039–1052.
4. Andrews, R.M., Kubacka, I., Chinnery, P.F., Lightowlers, R.N., Turnbull, D.M., Howell, N., Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat. Genet., 23(2), 1999 147–147.
5. Anglin, R.E., Garside, S.L., Tarnopolsky, M.A., Mazurek, M.F., Rosebush, P.I., The psychiatric manifestations of mitochondrial disorders: a case and review of the literature. J. Clin. Psychiatry 73:4 (2012), 506–512.
6. Anglin, R.E., Mazurek, M.F., Tarnopolsky, M.A., Rosebush, P.I., The mitochondrial genome and psychiatric illness. Am. J. Med. Genet. B Neuropsychiatr. Genet. 159B:7 (2012), 749–759.
7. Araujo, G., Rosa, V., Lin, K., Caboclo, L., Sakamoto, A., Yacubian, E., Prevalence of psychiatric disorders in a series of patients with mesial temporal sclerosis compared to a group with juvenile myoclonic epilepsy. Epilepsia, 48, 2007 164–164.
8. Atilano, S.R., Malik, D., Chwa, M., Caceres-Del-Carpio, J., Nesburn, A.B., Boyer, D.S., Kuppermann, B.D., Jazwinski, S.M., Miceli, M.V., Wallace, D.C., Udar, N., Kenney, M.C., Mitochondrial DNA variants can mediate methylation status of inflammation, angiogenesis and signaling genes. Hum. Mol. Genet. 24:16 (2015), 4491–4503.
9. Bertolino, A., Frye, M., Callicott, J.H., Mattay, V.S., Rakow, R., Shelton-Repella, J., Post, R., Weinberger, D.R., Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol. Psychiatry 53:10 (2003), 906–913.
10. Biffi, A., Anderson, C.D., Nalls, M.A., Rahman, R., Sonni, A., Cortellini, L., Rost, N.S., Matarin, M., Hernandez, D.G., Plourde, A., de Bakker, P.I.W., Ross, O.A., Greenberg, S.M., Furie, K.L., Meschia, J.F., Singleton, A.B., Saxena, R., Rosand, J., Principal-component analysis for assessment of population stratification in mitochondrial medical genetics. Am. J. Hum. Genet. 86:6 (2010), 904–917.
11. Bijarnia-Mahay, S., Haberle, J., Rufenacht, V., Shigematsu, Y., Saxena, R., Verma, I.C., Citrin deficiency: a treatable cause of acute psychosis in adults. Neurol. India 63:2 (2015), 220–222.
12. Bond, D.J., Andreazza, A.C., Hughes, J., Dhanoa, T., Torres, I.J., Kozicky, J.M., Young, L.T., Lam, R.W., Yatham, L.N., Association of peripheral inflammation with body mass index and depressive relapse in bipolar disorder. Psychoneuroendocrinology 65 (2016), 76–83.
13. Bouaziz, M., Ambroise, C., Guedj, M., Accounting for population stratification in practice: a comparison of the main strategies dedicated to genome-wide association studies. PLoS One, 6(12), 2011.
14. Chang, C.C., Jou, S.H., Lin, T.T., Liu, C.S., Mitochondrial DNA variation and increased oxidative damage in euthymic patients with bipolar disorder. Psychiatry Clin. Neurosci. 68:7 (2014), 551–557.
15. Chinnery, P.F., Turnbull, D.M., Mitochondrial DNA and disease. Lancet 354:Suppl. 1 (1999), SI17–21.
16. Clay, H.B., Sillivan, S., Konradi, C., Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int. J. Dev. Neurosci. 29:3 (2011), 311–324.
17. Dager, S.R., Corrigan, N.M., Richards, T.L., Posse, S., Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders. Top. Magn. Reson Imaging 19:2 (2008), 81–96.
18. Dager, S.R., Friedman, S.D., Parow, A., Demopulos, C., Stoll, A.L., Lyoo, I.K., Dunner, D.L., Renshaw, P.F., Brain metabolic alterations in medication-free patients with bipolar disorder. Arch. Gen. Psychiatry 61:5 (2004), 450–458.
19. de Sousa, R.T., Machado-Vieira, R., Zarate, C.A. Jr., Manji, H.K., Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder. Expert Opin. Ther. Targets 18:10 (2014), 1131–1147.
20. Dejean de la Batie, C., Barbier, V., Valayannopoulos, V., Touati, G., Maltret, A., Brassier, A., Arnoux, J.B., Grevent, D., Chadefaux, B., Ottolenghi, C., Canoui, P., de Lonlay, P., Acute psychosis in propionic acidemia: 2 case reports. J. Child. Neurol. 29:2 (2014), 274–279.
21. Finnila, S., Lehtonen, M.S., Majamaa, K., Phylogenetic network for European mtDNA. Am. J. Hum. Genet. 68:6 (2001), 1475–1484.
22. Frye, M.A., McElroy, S.L., Fuentes, M., Sutor, B., Schak, K.M., Galardy, C.W., Palmer, B.A., Prieto, M.L., Kung, S., Sola, C.L., Ryu, E., Veldic, M., Geske, J., Cuellar-Barboza, A., Seymour, L.R., Mori, N., Crowe, S., Rummans, T.A., Biernacka, J.M., Development of a bipolar disorder biobank: differential phenotyping for subsequent biomarker analyses. Int. J. Bipolar Disord., 3(1), 2015, 30.
23. Frye, M.A., Watzl, J., Banakar, S., O'Neill, J., Mintz, J., Davanzo, P., Fischer, J., Chirichigno, J.W., Ventura, J., Elman, S., Tsuang, J., Walot, I., Thomas, M.A., Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression. Neuropsychopharmacology 32:12 (2007), 2490–2499.
24. Gomez-Duran, A., Pacheu-Grau, D., Lopez-Gallardo, E., Diez-Sanchez, C., Montoya, J., Lopez-Perez, M.J., Ruiz-Pesini, E., Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups. Hum. Mol. Genet. 19:17 (2010), 3343–3353.
25. Guo, B., Zhai, D., Cabezas, E., Welsh, K., Nouraini, S., Satterthwait, A.C., Reed, J.C., Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature 423:6938 (2003), 456–461.
26. Gurses, C., Azakli, H., Alptekin, A., Cakiris, A., Abaci, N., Arikan, M., Kursun, O., Gokyigit, A., Ustek, D., Mitochondrial DNA profiling via genomic analysis in mesial temporal lobe epilepsy patients with hippocampal sclerosis. Gene 538:2 (2014), 323–327.
27. Hamdani, N., Doukhan, R., Kurtlucan, O., Tamouza, R., Leboyer, M., Immunity, inflammation, and bipolar disorder: diagnostic and therapeutic implications. Curr. Psychiatry Rep., 15(9), 2013, 387.
28. Hamshere, M.L., Schulze, T.G., Schumacher, J., Corvin, A., Owen, M.J., Jamra, R.A., Propping, P., Maier, W., Orozco y Diaz, G., Mayoral, F., Rivas, F., Jones, I., Jones, L., Kirov, G., Gill, M., Holmans, P.A., Nothen, M.M., Cichon, S., Rietschel, M., Craddock, N., Mood-incongruent psychosis in bipolar disorder: conditional linkage analysis shows genome-wide suggestive linkage at 1q32.3, 7p13 and 20q13.31. Bipolar Disord. 11:6 (2009), 610–620.
29. Kato, T., Takahashi, Y., Deletion of leukocyte mitochondrial DNA in bipolar disorder. J. Affect Disord. 37:2–3 (1996), 67–73.
30. Kazuno, A.A., Munakata, K., Mori, K., Nanko, S., Kunugi, H., Nakamura, K., Mori, N., Yamada, K., Yoshikawa, T., Kato, N., Kato, T., Mitochondrial DNA haplogroup analysis in patients with bipolar disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B:2 (2009), 243–247.
31. Kenney, M.C., Chwa, M., Atilano, S.R., Falatoonzadeh, P., Ramirez, C., Malik, D., Tarek, M., Del Carpio, J.C., Nesburn, A.B., Boyer, D.S., Kuppermann, B.D., Vawter, M.P., Jazwinski, S.M., Miceli, M.V., Wallace, D.C., Udar, N., Molecular and bioenergetic differences between cells with African versus European inherited mitochondrial DNA haplogroups: implications for population susceptibility to diseases. Biochim. Biophys. Acta 1842:2 (2014), 208–219.
32. Kilbaugh, T.J., Lvova, M., Karlsson, M., Zhang, Z., Leipzig, J., Wallace, D.C., Margulies, S.S., Peripheral blood mitochondrial DNA as a biomarker of cerebral mitochondrial dysfunction following Traumatic brain injury in a Porcine model. PLoS One, 10(6), 2015, e0130927.
33. Kirov, G., Murphy, K.C., Arranz, M.J., Jones, I., McCandles, F., Kunugi, H., Murray, R.M., McGuffin, P., Collier, D.A., Owen, M.J., Craddock, N., Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder. Mol. Psychiatry 3:4 (1998), 342–345.
34. Kloss-Brandstatter, A., Pacher, D., Schonherr, S., Weissensteiner, H., Binna, R., Specht, G., Kronenberg, F., HaploGrep: a fast and reliable algorithm for automatic classification of mitochondrial DNA haplogroups. Hum. Mutat. 32:1 (2011), 25–32.
35. Koboldt, D.C., Chen, K., Wylie, T., Larson, D.E., McLellan, M.D., Mardis, E.R., Weinstock, G.M., Wilson, R.K., Ding, L., VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics 25:17 (2009), 2283–2285.
36. Konradi, C., Eaton, M., MacDonald, M.L., Walsh, J., Benes, F.M., Heckers, S., Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch. Gen. Psychiatry 61:3 (2004), 300–308.
37. Leboyer, M., Bellivier, F., Nosten-Bertrand, M., Jouvent, R., Pauls, D., Mallet, J., Psychiatric genetics: search for phenotypes. Trends Neurosci. 21:3 (1998), 102–105.
38. Lee, C., Yen, K., Cohen, P., Humanin: a harbinger of mitochondrial-derived peptides?. Trends Endocrinol. Metab. 24:5 (2013), 222–228.
39. Lee, C., Zeng, J., Drew, B.G., Sallam, T., Martin-Montalvo, A., Wan, J., Kim, S.J., Mehta, H., Hevener, A.L., de Cabo, R., Cohen, P., The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 21:3 (2015), 443–454.
40. Li, H., Liu, D., Lu, J., Bai, Y., Physiology and pathophysiology of mitochondrial DNA. Adv. Exp. Med. Biol. 942 (2012), 39–51.
41. Magner, M., Honzik, T., Tesarova, M., Dvorakova, V., Hansikova, H., Raboch, J., Zeman, J., Psychiatric disturbances in five patients with MELAS syndrome. Psychiatr. Pol. 48:5 (2014), 1035–1045.
42. Marchbanks, R.M., Ryan, M., Day, I.N.M., Owen, M., McGuffin, P., Whatley, S.A., A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress. Schizophr. Res. 65:1 (2003), 33–38.
43. Martorell, L., Segues, T., Folch, G., Valero, J., Joven, J., Labad, A., Vilella, E., New variants in the mitochondrial genomes of schizophrenic patients. Eur. J. Hum. Genet. 14:5 (2006), 520–528.
44. Miyazono, F., Schneider, P.M., Metzger, R., Warnecke-Eberz, U., Baldus, S.E., Dienes, H.P., Aikou, T., Hoelscher, A.H., Mutations in the mitochondrial DNA D-Loop region occur frequently in adenocarcinoma in Barrett's esophagus. Oncogene 21:23 (2002), 3780–3783.
45. Montiel-Sosa, F., Ruiz-Pesini, E., Enriquez, J.A., Marcuello, A., Diez-Sanchez, C., Montoya, J., Wallace, D.C., Lopez-Perez, M.J., Differences of sperm motility in mitochondrial DNA haplogroup U sublineages. Gene 368 (2006), 21–27.
46. Muller, D.J., de Luca, V., Sicard, T., King, N., Strauss, J., Kennedy, J.L., Brain-derived neurotrophic factor (BDNF) gene and rapid-cycling bipolar disorder: family-based association study. Br. J. Psychiatry 189 (2006), 317–323.
47. Munakata, K., Tanaka, M., Mori, K., Washizuka, S., Yoneda, M., Tajima, O., Akiyama, T., Nanko, S., Kunugi, H., Tadokoro, K., Ozaki, N., Inada, T., Sakamoto, K., Fukunaga, T., Iijima, Y., Iwata, N., Tatsumi, M., Yamada, K., Yoshikawa, T., Kato, T., Mitochondrial DNA 3644T–>C mutation associated with bipolar disorder. Genomics 84:6 (2004), 1041–1050.
48. Muneer, A., Bipolar disorder: role of inflammation and the development of disease biomarkers. Psychiatry Investig. 13:1 (2016), 18–33.
49. Nassan, M., Croarkin, P.E., Luby, J.L., Veldic, M., Joshi, P.T., McElroy, S.L., Post, R.M., Walkup, J.T., Cercy, K., Geske, J.R., Wagner, K.D., Cuellar-Barboza, A.B., Casuto, L., Lavebratt, C., Schalling, M., Jensen, P.S., Biernacka, J.M., Frye, M.A., Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with early-onset bipolar disorder. Bipolar Disord. 17:6 (2015), 645–652.
50. Pfaffenseller, B., Fries, G.R., Wollenhaupt-Aguiar, B., Colpo, G.D., Stertz, L., Panizzutti, B., Magalhaes, P.V., Kapczinski, F., Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder. Expert Rev. Neurother. 13:7 (2013), 827–842.
51. Raule, N., Sevini, F., Santoro, A., Altilia, S., Franceschi, C., Association studies on human mitochondrial DNA: methodological aspects and results in the most common age-related diseases. Mitochondrion 7:1–2 (2007), 29–38.
52. Ruffalo, M., LaFramboise, T., Koyuturk, M., Comparative analysis of algorithms for next-generation sequencing read alignment. Bioinformatics 27:20 (2011), 2790–2796.
53. Samuels, D.C., Li, C., Li, B., Song, Z., Torstenson, E., Boyd Clay, H., Rokas, A., Thornton-Wells, T.A., Moore, J.H., Hughes, T.M., Hoffman, R.D., Haines, J.L., Murdock, D.G., Mortlock, D.P., Williams, S.M., Recurrent tissue-specific mtDNA mutations are common in humans. PLoS Genet., 9(11), 2013, e1003929.
54. Saunders, E.H., Scott, L.J., McInnis, M.G., Burmeister, M., Familiality and diagnostic patterns of subphenotypes in the National Institutes of Mental Health bipolar sample. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B:1 (2008), 18–26.
55. Scola, G., Kim, H.K., Young, L.T., Andreazza, A.C., A fresh look at complex I in microarray data: clues to understanding disease-specific mitochondrial alterations in bipolar disorder. Biol. Psychiatry 73:2 (2013), e4–5.
56. Sequeira, A., Rollins, B., Magnan, C., van Oven, M., Baldi, P., Myers, R.M., Barchas, J.D., Schatzberg, A.F., Watson, S.J., Akil, H., Bunney, W.E., Vawter, M.P., Mitochondrial mutations in subjects with psychiatric disorders. PLoS One, 10(5), 2015, e0127280.
57. Sjoholm, L.K., Backlund, L., Cheteh, E.H., Ek, I.R., Frisen, L., Schalling, M., Osby, U., Lavebratt, C., Nikamo, P., CRY2 is associated with rapid cycling in bipolar disorder patients. PLoS One, 5(9), 2010, e12632.
58. Stork, C., Renshaw, P.F., Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol. Psychiatry 10:10 (2005), 900–919.
59. Suvisaari, J., Mantere, O., Inflammation theories in psychotic disorders: a critical review. Infect. Disord. Drug Targets 13:1 (2013), 59–70.
60. Szczepanowska, K., Trifunovic, A., Different faces of mitochondrial DNA mutators. Biochim. Biophys. Acta 1847:11 (November 2015), 1362–1372.
61. Torroni, A., Huoponen, K., Francalacci, P., Petrozzi, M., Morelli, L., Scozzari, R., Obinu, D., Savontaus, M.L., Wallace, D.C., Classification of European mtDNAs from an analysis of three European populations. Genetics 144:4 (1996), 1835–1850.
62. van Oven, M., Kayser, M., Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum. Mutat. 30:2 (2009), E386–E394.
63. Wallace, D.C., The mitochondrial genome in human adaptive radiation and disease: on the road to therapeutics and performance enhancement. Gene 354 (2005), 169–180.
64. Wallace, D.C., Chalkia, D., Mitochondrial DNA genetics and the heteroplasmy conundrum in evolution and disease. Cold Spring Harb. Perspect. Biol., 5(11), 2013, a021220.
65. Weber, W.A., Dudley, J., Lee, J.H., Strakowski, S.M., Adler, C.M., DelBello, M.P., A pilot study of alterations in high energy phosphoryl compounds and intracellular pH in unmedicated adolescents with bipolar disorder. J. Affect Disord. 150:3 (2013), 1109–1113.